183 results
Page 3 of 10
S-8
EX-23.1
knun40vcfefz4mtp61
14 Nov 22
Registration of securities for employees
5:16pm
S-8
gg3x1w8ve3u
14 Nov 22
Registration of securities for employees
5:16pm
DEFA14A
c8lj6bpp8a
28 Oct 22
Additional proxy soliciting materials
12:37pm
424B3
qc87w2p1
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-99.1
fr36abb3ru1g
23 Sep 22
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
4:53pm
POS AM
445tkd
20 Sep 22
Prospectus update (post-effective amendment)
9:15am
POS AM
iihqnqemjpeu
20 Sep 22
Prospectus update (post-effective amendment)
9:14am
POS AM
ndd2g8i5 9z34fc
20 Sep 22
Prospectus update (post-effective amendment)
9:14am
POS AM
e7d lmq5qdhb
20 Sep 22
Prospectus update (post-effective amendment)
9:13am
POS AM
l11pqcgjr qic356xm9r
20 Sep 22
Prospectus update (post-effective amendment)
9:10am
8-K
EX-4.2
met6sb4 gelc620ktnju
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.3
ny3 lsasft0olj7u0h
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
i7mu 1kuxbm341ed
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm